Medication Safety

Ensuring the safe use of amphotericin B injection

25 November 2025Amphotericin B liposomal products and Fungizone are not interchangeable. Take action to prevent death caused by inadvertent mis-selection

Including medicines with Risk Minimisation Measures (RMM) in PGDs

10 November 2025Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

MSATS – Safe use of medicines in palliative and end of life care

24 September 2025Discussion of medication safety challenges within palliative and end of life care; inspiring partnership across the system.

Minimising risks associated with administration of injectable iron

14 August 2025Administration of injectable iron has a risk of hypersensitivity and skin staining. Mitigation strategies can help minimise harm.

Managing the risk of confusion between injectable iron products

14 August 2025Minimising the risk of confusion between different injectable iron products may prevent inadvertent harm.

Addressing medication safety inequalities across the system

31 July 2025Strategies and signposting to support actions to address medication safety inequalities.

Safer use of time critical medicines

1 July 2025Sharing what has been learnt so far from the national safer use of time critical medicines programme, including improvement interventions.

Safer use of time critical medicines programme

28 May 2025An update on the programme's progress, including the quality improvement collaborative, wider community of practice and related outputs.

Understanding when a check adds value to medication processes

2 May 2025Understanding what a check is, the principles of an effective check and factors to consider if introducing a check to a medication process.

Developing insulin safety across a system

1 May 2025Strategies, signposting and initiatives to support safer use of insulin.